Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-135789
Filing Date
2024-12-12
Accepted
2024-12-12 16:12:05
Documents
2
Period of Report
2024-12-10

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1515
2 EX-24.1 atyr-ex24_1.htm EX-24.1 11892
  Complete submission text file 0000950170-24-135789.txt   14896
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Issuer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O NEUROCRINE BIOSCIENCES, INC. 12790 EL CAMINO REAL SAN DIEGO CA 92130
Business Address
BENEVICH ERIC (Reporting) CIK: 0001643653 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37378 | Film No.: 241544943